Life Science Fundraising & Investment
24 March 2026 - Pre-day forums (Life Science Companies only), FIL (Feira Internacional de Lisboa)25-26 March 2026 - Main days, Lisbon Congress Centre, Lisbon, Portugal Mark BodmerCEO at Nucleome TherapeuticsSpeaker
Profile
Mark joined Nucleome in 2024. His long career includes multiple CEO and CSO roles in biotech and research leadership in big pharma, spanning US/Europe/UK. This has provided him with broad experience in drug discovery and development, including six currently marketed biologics, as well as company-founding and building, financing, and deal-making.
Agenda Sessions
Silicon Meets Science: AI's Make-or-Break Moment in Biotech
, 14:00View Session